Medicine

Her name was on the patent for tamoxifen, but Dora Richardson’s story was lost until now

An epidemiologist explores a troubling rise in early-onset breast cancer diagnoses and discusses the potential link to chronic exposure to endocrine disruptors.

People recovering from substance use disorders need homes, jobs and medication-centered, quality health care, not just a bed in a residential treatment center

In her book Wonder Drug, Jennifer Vanderbes explores the history of thalidomide’s secret history—and harms—in the U.S.

How do you stop implicit bias from getting in the way of better health? This doctor wants to make learning how to manage bias as important as learning how to suture.

We talk to Cristina Gonzalez, a physician at New York University, who runs a lab that uses simulations to help medical professionals check their implicit bias at the exam room door.

Medical professionals who connect with their patients’ language and culture provide better care

Tools and networks that have helped control HIV/AIDS are now working against mpox

Decades after FDA medical examiner Frances Oldham Kelsey stopped thalidomide from going on the market in the U.S., the legacy of the drug persists

Both Trump and Harris pledge to make drug prices affordable and health care accessible. Here’s how their policies differ

 FDA medical examiner Frances Oldham Kelsey saved American lives by refusing to approve thalidomide. But millions of pills had been sent to doctors in the U.S. for so-called clinical trials

A new class of drugs treats pain at the periphery. Here’s what that could mean for those with chronic pain.